Author | Matthew B. Yurgelun, MD | OncLive

Author | Matthew B. Yurgelun, MD


Online Tool Estimates the Risk for Lynch Syndrome

February 05, 2019


Because specific risk-reducing interventions may be available, it is important to identify individuals with germline variants in cancer susceptibility genes.

Dr. Yurgelun Discusses Germline Testing in CRC

May 03, 2017


Matthew B. Yurgelun, MD, assistant professor of Medicine, Harvard Medical School, and a researcher at the Dana-Farber Cancer Institute, discusses germline testing in colorectal cancer.

Dr. Matthew Yurgelun on Pathogenic Mutations in CRC

September 22, 2016


Matthew B. Yurgelun, MD, Targeted Oncology, Yurgelun, Instructor in Medicine, Harvard Medical School, discusses a recent study which uncovered BRCA1 and BRCA2 mutations as possible risk markers for colorectal cancer.